These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11496149)

  • 1. Identification of amyloid-beta binding sites using an antisense peptide approach.
    Milton NG; Mayor NP; Rawlinson J
    Neuroreport; 2001 Aug; 12(11):2561-6. PubMed ID: 11496149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease.
    Yan SD; Fu J; Soto C; Chen X; Zhu H; Al-Mohanna F; Collison K; Zhu A; Stern E; Saido T; Tohyama M; Ogawa S; Roher A; Stern D
    Nature; 1997 Oct; 389(6652):689-95. PubMed ID: 9338779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of amyloid beta-peptide to mitochondrial hydroxyacyl-CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer's disease.
    Oppermann UC; Salim S; Tjernberg LO; Terenius L; Jörnvall H
    FEBS Lett; 1999 May; 451(3):238-42. PubMed ID: 10371197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human brain L-3-hydroxyacyl-coenzyme A dehydrogenase is identical to an amyloid beta-peptide-binding protein involved in Alzheimer's disease.
    He XY; Schulz H; Yang SY
    J Biol Chem; 1998 Apr; 273(17):10741-6. PubMed ID: 9553139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of ERAB/L-3-hydroxyacyl-coenzyme A dehydrogenase type II activity in Abeta-induced cytotoxicity.
    Yan SD; Shi Y; Zhu A; Fu J; Zhu H; Zhu Y; Gibson L; Stern E; Collison K; Al-Mohanna F; Ogawa S; Roher A; Clarke SG; Stern DM
    J Biol Chem; 1999 Jan; 274(4):2145-56. PubMed ID: 9890977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease. The ins and outs of amyloid-beta.
    Beyreuther K; Masters CL
    Nature; 1997 Oct; 389(6652):677-8. PubMed ID: 9338775
    [No Abstract]   [Full Text] [Related]  

  • 7. Deposition of Alzheimer's vascular amyloid-beta is associated with decreased expression of brain L-3-hydroxyacyl-coenzyme A dehydrogenase (ERAB).
    Frackowiak J; Mazur-Kolecka B; Kaczmarski W; Dickson D
    Brain Res; 2001 Jul; 907(1-2):44-53. PubMed ID: 11430884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERAB contains a putative noncleavable signal peptide.
    Sambamurti K; Lahiri DK
    Biochem Biophys Res Commun; 1998 Aug; 249(2):546-9. PubMed ID: 9712734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-beta binding alcohol dehydrogenase (ABAD).
    Powell AJ; Read JA; Banfield MJ; Gunn-Moore F; Yan SD; Lustbader J; Stern AR; Stern DM; Brady RL
    J Mol Biol; 2000 Oct; 303(2):311-27. PubMed ID: 11023795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of peptides that specifically bind Abeta1-40 amyloid in vitro and amyloid plaques in Alzheimer's disease brain using phage display.
    Kang CK; Jayasinha V; Martin PT
    Neurobiol Dis; 2003 Oct; 14(1):146-56. PubMed ID: 13678675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active site environment of heme-bound amyloid β peptide associated with Alzheimer's disease.
    Pramanik D; Dey SG
    J Am Chem Soc; 2011 Jan; 133(1):81-7. PubMed ID: 21141958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Amyloid and its binding protein in the hippocampus of diabetic mice: effect of APP17 peptide.
    Shuli S; Yongmei Z; Zhiwei Z; Zhijuan J
    Neuroreport; 2001 Oct; 12(15):3317-9. PubMed ID: 11711878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical modifications of amyloid-β(1-42) have a significant impact on the repertoire of brain amyloid-β(1-42) binding proteins.
    Medvedev AE; Buneeva OA; Kopylov AT; Mitkevich VA; Kozin SA; Zgoda VG; Makarov AA
    Biochimie; 2016; 128-129():55-8. PubMed ID: 27400251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of Mitochondrial 17β-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer's Disease.
    He XY; Isaacs C; Yang SY
    J Alzheimers Dis; 2018; 62(2):665-673. PubMed ID: 29480196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of amyloid-beta at the serine 26 residue by human cdc2 kinase.
    Milton NG
    Neuroreport; 2001 Dec; 12(17):3839-44. PubMed ID: 11726805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining binding sites of polycyclic aromatic small molecule-based amyloid-beta peptide aggregation modulators using sequence-specific antibodies.
    Irwin JA; Edward Wong H; Kwon I
    Anal Biochem; 2015 Feb; 470():61-70. PubMed ID: 25449301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
    Sharma S; Nehru B; Saini A
    Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of genetic variants of amyloid β peptide by neuronal and non-neuronal cells.
    Panchal M; El Abida B; Lazar N; Fahy C; Dubost L; Friguet B; Rholam M
    Protein Pept Lett; 2013 May; 20(5):550-61. PubMed ID: 23092134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions.
    McLaurin J; Fraser PE
    Eur J Biochem; 2000 Nov; 267(21):6353-61. PubMed ID: 11029577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.